Dobutamine 70436-0203-82
- Manufacturer
- Slate Run Pharmaceuticals
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 3, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA216131
Need to source Dobutamine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dobutamine Hydrochloride | 250 mg/20mL |
Drug Class
Adrenergic beta-Agonists [MoA]beta-Adrenergic Agonist [EPC]
Selected Package
70436-0203-82Selected10 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-82) / 20 mL in 1 VIAL, SINGLE-DOSE
Other packages for this product(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-80) / 20 mL in 1 VIAL, SINGLE-DOSE